Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ENZALUTAMIDE Cause Atrioventricular block complete? 10 Reports in FDA Database

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Atrioventricular block complete have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.0% of all adverse event reports for ENZALUTAMIDE.

10
Reports of Atrioventricular block complete with ENZALUTAMIDE
0.0%
of all ENZALUTAMIDE reports
1
Deaths
4
Hospitalizations

How Dangerous Is Atrioventricular block complete From ENZALUTAMIDE?

Of the 10 reports, 1 (10.0%) resulted in death, 4 (40.0%) required hospitalization, and 3 (30.0%) were considered life-threatening.

Is Atrioventricular block complete Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ENZALUTAMIDE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does ENZALUTAMIDE Cause?

Fatigue (8,891) Death (6,680) Malignant neoplasm progression (4,696) Prostatic specific antigen increased (3,731) Asthenia (3,589) Drug ineffective (3,468) Hot flush (3,144) Decreased appetite (3,069) Nausea (2,898) Dizziness (2,776)

What Other Drugs Cause Atrioventricular block complete?

BISOPROLOL (261) VERAPAMIL (210) METOPROLOL (209) AMLODIPINE (149) DILTIAZEM (141) RITUXIMAB (139) AMIODARONE (138) LACOSAMIDE (130) ATORVASTATIN (127) PEMBROLIZUMAB (122)

Which ENZALUTAMIDE Alternatives Have Lower Atrioventricular block complete Risk?

ENZALUTAMIDE vs EPCORITAMAB ENZALUTAMIDE vs EPCORITAMAB-BYSP ENZALUTAMIDE vs EPERISONE ENZALUTAMIDE vs EPHEDRINE ENZALUTAMIDE vs EPINASTINE

Related Pages

ENZALUTAMIDE Full Profile All Atrioventricular block complete Reports All Drugs Causing Atrioventricular block complete ENZALUTAMIDE Demographics